vs
Side-by-side financial comparison of CONSTELLIUM SE (CSTM) and Organon & Co. (OGN). Click either name above to swap in a different company.
CONSTELLIUM SE is the larger business by last-quarter revenue ($2.2B vs $1.5B, roughly 1.5× Organon & Co.). CONSTELLIUM SE runs the higher net margin — 5.1% vs -13.6%, a 18.7% gap on every dollar of revenue. CONSTELLIUM SE produced more free cash flow last quarter ($109.0M vs $96.0M).
Constellium SE is an American-Swiss, French-based global manufacturer of aluminium rolled products, extruded products, and structural parts based on a large variety of advanced alloys. Constellium's C-TEC research center has been credited for advancing technology in the field of advanced aluminium alloy. Constellium primarily serves the aerospace, automotive, and packaging sectors. Large clients include Mercedes-Benz, Audi, BMW, Fiat Chrysler Automotive, Ford, Airbus, Boeing, and Bombardier.
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
CSTM vs OGN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.2B | $1.5B |
| Net Profit | $112.0M | $-205.0M |
| Gross Margin | — | 49.2% |
| Operating Margin | 7.5% | -9.8% |
| Net Margin | 5.1% | -13.6% |
| Revenue YoY | — | -5.3% |
| Net Profit YoY | — | -288.1% |
| EPS (diluted) | $0.79 | $-0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.2B | $1.5B | ||
| Q3 25 | $2.2B | $1.6B | ||
| Q2 25 | $2.1B | $1.6B | ||
| Q1 25 | $2.0B | $1.5B | ||
| Q4 24 | — | $1.6B | ||
| Q3 24 | — | $1.6B | ||
| Q2 24 | $1.9B | $1.6B | ||
| Q1 24 | — | $1.6B |
| Q4 25 | $112.0M | $-205.0M | ||
| Q3 25 | $88.0M | $160.0M | ||
| Q2 25 | $36.0M | $145.0M | ||
| Q1 25 | $37.0M | $87.0M | ||
| Q4 24 | — | $109.0M | ||
| Q3 24 | — | $359.0M | ||
| Q2 24 | $76.0M | $195.0M | ||
| Q1 24 | — | $201.0M |
| Q4 25 | — | 49.2% | ||
| Q3 25 | — | 53.5% | ||
| Q2 25 | — | 54.8% | ||
| Q1 25 | — | 55.6% | ||
| Q4 24 | — | 56.3% | ||
| Q3 24 | — | 58.3% | ||
| Q2 24 | — | 58.4% | ||
| Q1 24 | — | 59.0% |
| Q4 25 | 7.5% | -9.8% | ||
| Q3 25 | 5.8% | 15.2% | ||
| Q2 25 | 2.7% | 14.4% | ||
| Q1 25 | 3.1% | 6.7% | ||
| Q4 24 | — | 8.1% | ||
| Q3 24 | — | 13.1% | ||
| Q2 24 | 5.4% | 14.6% | ||
| Q1 24 | — | 14.5% |
| Q4 25 | 5.1% | -13.6% | ||
| Q3 25 | 4.1% | 10.0% | ||
| Q2 25 | 1.7% | 9.1% | ||
| Q1 25 | 1.9% | 5.8% | ||
| Q4 24 | — | 6.8% | ||
| Q3 24 | — | 22.7% | ||
| Q2 24 | 3.9% | 12.1% | ||
| Q1 24 | — | 12.4% |
| Q4 25 | $0.79 | $-0.78 | ||
| Q3 25 | $0.62 | $0.61 | ||
| Q2 25 | $0.25 | $0.56 | ||
| Q1 25 | $0.26 | $0.33 | ||
| Q4 24 | — | $0.42 | ||
| Q3 24 | — | $1.38 | ||
| Q2 24 | $0.51 | $0.75 | ||
| Q1 24 | — | $0.78 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $120.0M | $574.0M |
| Total DebtLower is stronger | $1.9B | $8.6B |
| Stockholders' EquityBook value | $952.0M | $752.0M |
| Total Assets | $5.4B | $12.9B |
| Debt / EquityLower = less leverage | 2.00× | 11.49× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $120.0M | $574.0M | ||
| Q3 25 | $122.0M | $672.0M | ||
| Q2 25 | $133.0M | $599.0M | ||
| Q1 25 | $118.0M | $547.0M | ||
| Q4 24 | — | $675.0M | ||
| Q3 24 | — | $763.0M | ||
| Q2 24 | — | $704.0M | ||
| Q1 24 | — | $575.0M |
| Q4 25 | $1.9B | $8.6B | ||
| Q3 25 | $2.0B | $8.8B | ||
| Q2 25 | $2.0B | $8.9B | ||
| Q1 25 | $1.9B | $9.0B | ||
| Q4 24 | — | $8.9B | ||
| Q3 24 | — | $8.7B | ||
| Q2 24 | — | $8.7B | ||
| Q1 24 | — | $8.7B |
| Q4 25 | $952.0M | $752.0M | ||
| Q3 25 | $845.0M | $906.0M | ||
| Q2 25 | $780.0M | $733.0M | ||
| Q1 25 | $745.0M | $542.0M | ||
| Q4 24 | — | $472.0M | ||
| Q3 24 | — | $493.0M | ||
| Q2 24 | $796.0M | $144.0M | ||
| Q1 24 | — | $48.0M |
| Q4 25 | $5.4B | $12.9B | ||
| Q3 25 | $5.4B | $13.6B | ||
| Q2 25 | $5.4B | $13.5B | ||
| Q1 25 | $5.2B | $13.2B | ||
| Q4 24 | — | $13.1B | ||
| Q3 24 | — | $12.8B | ||
| Q2 24 | — | $12.2B | ||
| Q1 24 | — | $11.9B |
| Q4 25 | 2.00× | 11.49× | ||
| Q3 25 | 2.34× | 9.74× | ||
| Q2 25 | 2.53× | 12.14× | ||
| Q1 25 | 2.56× | 16.52× | ||
| Q4 24 | — | 18.81× | ||
| Q3 24 | — | 17.75× | ||
| Q2 24 | — | 60.11× | ||
| Q1 24 | — | 181.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $218.0M | $141.0M |
| Free Cash FlowOCF − Capex | $109.0M | $96.0M |
| FCF MarginFCF / Revenue | 5.0% | 6.4% |
| Capex IntensityCapex / Revenue | 5.0% | 3.0% |
| Cash ConversionOCF / Net Profit | 1.95× | — |
| TTM Free Cash FlowTrailing 4 quarters | $159.0M | $538.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $218.0M | $141.0M | ||
| Q3 25 | $99.0M | $264.0M | ||
| Q2 25 | $114.0M | $220.0M | ||
| Q1 25 | $58.0M | $75.0M | ||
| Q4 24 | — | $390.0M | ||
| Q3 24 | — | $141.0M | ||
| Q2 24 | $138.0M | $332.0M | ||
| Q1 24 | — | $76.0M |
| Q4 25 | $109.0M | $96.0M | ||
| Q3 25 | $24.0M | $218.0M | ||
| Q2 25 | $37.0M | $181.0M | ||
| Q1 25 | $-11.0M | $43.0M | ||
| Q4 24 | — | $335.0M | ||
| Q3 24 | — | $99.0M | ||
| Q2 24 | $54.0M | $300.0M | ||
| Q1 24 | — | $30.0M |
| Q4 25 | 5.0% | 6.4% | ||
| Q3 25 | 1.1% | 13.6% | ||
| Q2 25 | 1.8% | 11.4% | ||
| Q1 25 | -0.6% | 2.8% | ||
| Q4 24 | — | 21.0% | ||
| Q3 24 | — | 6.3% | ||
| Q2 24 | 2.8% | 18.7% | ||
| Q1 24 | — | 1.8% |
| Q4 25 | 5.0% | 3.0% | ||
| Q3 25 | 3.5% | 2.9% | ||
| Q2 25 | 3.7% | 2.4% | ||
| Q1 25 | 3.5% | 2.1% | ||
| Q4 24 | — | 3.5% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | 4.3% | 2.0% | ||
| Q1 24 | — | 2.8% |
| Q4 25 | 1.95× | — | ||
| Q3 25 | 1.13× | 1.65× | ||
| Q2 25 | 3.17× | 1.52× | ||
| Q1 25 | 1.57× | 0.86× | ||
| Q4 24 | — | 3.58× | ||
| Q3 24 | — | 0.39× | ||
| Q2 24 | 1.82× | 1.70× | ||
| Q1 24 | — | 0.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CSTM
| Packaging Rolled Products | $1.0B | 46% |
| Automotive Rolled Products | $318.0M | 14% |
| Aerospace Rolled Products | $270.0M | 12% |
| Transportation Industry Defense And Other Rolled Products | $232.0M | 11% |
| Automotive Extruded Products | $220.0M | 10% |
| Other Extruded Products | $132.0M | 6% |
| Specialty And Other Thin Rolled Products | $22.0M | 1% |
OGN
Segment breakdown not available.
